A Novel VPS13A Deletion in VPS13A Disease (Chorea-Acanthocytosis): A Case Report with Brief Literature Summary.

Benedetta Perrone, Viviana Mosca, Martina Pecoraro, Paola Ruffo, Elda Del Giudice, Alberta Leon, Martina Maino, Vincenzo La Bella, Rossella Spataro, Francesca Luisa Conforti

Journal: International journal of molecular sciences 2025;26(23):

PMID: 41373679

Abstract

VPS13A disease is a rare, autosomal-recessive, neurodegenerative disorder characterized by involuntary movements, orofacial dystonia, seizures, psychiatric symptoms, and the presence of spiky, deformed red blood cells (acanthocytes). The disease is caused by mutations in the VPS13A gene, which encodes the VPS13A protein (previously known as chorein). This protein is a member of the family of bridge-like lipid transport proteins, involved in bulk lipid transfer between membranes and intracellular vesicle trafficking. We describe the case of a 37-year-old woman with gait instability, semi-flexed legs, and involuntary distal muscle movements. Genetic testing was performed using next-generation sequencing (NGS), followed by molecular analysis. Fibroblasts from the patient, her mother, and a healthy control were analyzed by immunofluorescence and Western blotting. NGS identified a novel homozygous 2.8 kb deletion encompassing exons 69-70 (69-70del) of the VPS13A gene (NM_033305.3). The same variant was detected in the patient's mother in a heterozygous state and her brother in a homozygous state. Although other deletions in the gene have been described, a comprehensive search of population variant databases and the existing literature did not reveal previous reports of this deletion. Fibroblasts from the patient, her mother and a healthy control were characterized. Functional assays showed a complete absence of the VPS13A protein in the patient's fibroblasts. This study expands the mutational spectrum of VPS13A-linked VPS13A disease and underlines the importance of comprehensive genetic analysis in atypical cases.

Address: Laboratory of Medical Genetics, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Rende, 87036 Cosenza, Italy.; Health Center, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Rende, 87036 Cosenza, Italy.; Lab of Neurochemistry, Department of Biomedicine, Neurosciences, and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90127 Palermo, Italy.; R&I Genetics Srl, 35127 Padua, Italy.; Intensive Neurorehabilitation Unit, Villa delle Ginestre Hospital, ASP Palermo, 90141 Palermo, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.